Spray-applied cell therapy with human allogeneic fibroblasts and keratinocytes for the treatment of chronic venous leg ulcers: a phase 2, multicentre, double-blind, randomised, placebo-controlled trial (Q61051157)
Jump to navigation
Jump to search
scientific article published in The Lancet
Language | Label | Description | Also known as |
---|---|---|---|
English | Spray-applied cell therapy with human allogeneic fibroblasts and keratinocytes for the treatment of chronic venous leg ulcers: a phase 2, multicentre, double-blind, randomised, placebo-controlled trial |
scientific article published in The Lancet |
Statements
Spray-applied cell therapy with human allogeneic fibroblasts and keratinocytes for the treatment of chronic venous leg ulcers: a phase 2, multicentre, double-blind, randomised, placebo-controlled trial (English)
William A Marston
Robert J Snyder
Tommy D Lee
D Innes Cargill
Herbert B Slade
3 August 2012